Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (CrossMab)
TypeName: Business Offer
Category:
Offer Date:2019/07/07
Country: United States
Summary: Recombinant Anti-CTLA4 x Anti-PD1 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can bind two factors simultaneously and enhance immune response. It is designed for the research of Tumors therapy.https://www.creative-biolabs.com/bsab/symbolsearch-ctla4%2520%2526%2520pd1.htm
Agriculture & Food
Business Services
Electronics, IT and Telecoms
Leisure & Tourism
Minerals
Textiles, Clothing, Leather,
Transport & Logistics
